Enterprises adopting AI cannot afford to be slowed by database lock-in. As the vector ecosystem evolves, the winners will be ...
Oracle CEO Mike Sicilia said on Tuesday that he is not concerned about an "AI bubble," adding that there is real value in ...
Oracle Corporation gained luster in 2025, outperforming market as it demonstrated ambition to leapfrog its peers. Learn more ...
CISA has confirmed that an Oracle E-Business Suite flaw tracked as CVE-2025-61884 is being exploited in attacks, adding it to ...
Summarization wasn’t new either. Oracle’s cloud AI stack — OCI Generative AI — already supported it. With the official ...
CNBC's Seema Mody joins 'Money Movers' to discuss Oracle's latest earnings. BREAKING: Former Trump National Security Adviser John Bolton surrenders to 18 counts ...
Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...
Recursion Pharmaceuticals (RXRX) shares ended the last trading session 8.2% higher at $5.52. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...
Envoy Air, American Airlines' largest regional carrier, suffered a hack in recent days as part of the wave of extortion ...
Oracle has linked an ongoing extortion campaign claimed by the Clop ransomware gang to E-Business Suite (EBS) vulnerabilities that were patched in July 2025. While the company has yet to attribute the ...
Thinking about what to do with Recursion Pharmaceuticals stock right now? You are not alone. In just the past week, the stock has jumped an impressive 19.2%, adding to an 18.5% surge over 30 days. It ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results